CDSCO · Public notice
CDSCO issues notice on raw-material and finished-formulation testing
Official source date: · Source checked
CDSCO has listed a notice on compliance with the Drugs Rules, 1945 for testing raw materials and finished formulations. QA and QC teams should review the official document against their testing arrangements.
Who should review this?
Indian pharmaceutical QA, QC and personnel responsible for testing arrangements.
What it means for pharmaceutical teams
The listed notice is a prompt to review the complete official instructions. The title alone is insufficient to determine the details applicable to an individual facility.
Practical review checklist
PharmaEdges reading prompts for your own applicability review:
- Read the linked CDSCO notice in full.
- Compare its scope with your raw-material and finished-product testing activities.
- Record any applicable follow-up through your approved quality procedures.
Official source and verification
Read the CDSCO source (opens in a new tab)
This article summarises the linked official material. The context and checklist are PharmaEdges explanatory commentary, not additional regulatory requirements. The source publication date is separate from this article’s publication date.
For a correction, contact PharmaEdges with the article URL and supporting source. Read our news publishing policy.
Related regulatory news
- EMA PRAC opens reviews of Deanxit and immunoglobulin safety reports
- EDQM highlights international API inspection cooperation report
- CDSCO lists ONDLS monitoring notice for high-risk solvent supply chains
- EMA announces permanent clinical-trial application advice from January 2027
- EMA publishes year-end 2026 advice for type I variation submissions